Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05288777
Title Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer (Breast53)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Virginia
Indications

breast cancer

Therapies

Capecitabine

Ado-trastuzumab emtansine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.